Céline Huot

ORCID: 0000-0003-3821-009X · 2 papers in corpus

article 2009

Behandlung mit einem intranasalen oder subkutan verabreichten LH-RH-Agonisten zur Unterdrückung der Ovarialfunktion bei der Behandlung der Endometriose

·doi:10.1159/000270926

article 1988

Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist inhibition of ovarian function in the treatment of endometriosis

American journal of obstetrics and gynecology ·doi:10.1016/0002-9378(88)90128-7

We have previously reported reversible hypogonadism induced by the intranasal administration of the luteinizing hormone-releasing hormone agonist buserelin as a new therapeutic approach for endometriosis. Thirteen patients were randomized t…